Lincoln Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025, to consider and approve unaudited Financial Results (Standalone and Consolidated) of the Company for the Third Quarter and Nine Months Ended 31st December, 2024 And Other Business if any.
The above information is a part of company’s filings submitted to BSE.